A Study to Learn About the Effectiveness of Cancer Medicines in Patients With Metastatic Non-small Cell Lung Cancer in Norway.

Condition:   Non-Small Cell Lung Cancer Interventions:   Drug: lorlatinib;   Drug: crizotinib;   Drug: brigatinib;   Drug: ceritinib;   Drug: alectinib;   Drug: atezolizumab;   Drug: bevacizumab;   Drug: paclitaxel;   Drug: carboplatin;   Drug: docetaxel;   Drug: erlotinib;   Drug: gefitinib;   Drug: afatinib;   Drug: dacomi tinib;   Drug: osimertinib;   Drug: pembrolizumab;   Drug: nivolumab;   Drug: entrectinib Sponsor:   Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials